• Home
  • News
    • Editorial
    • MD(e)B(unker)
    • Related Researches
      • Di Bella's Foundation
      • 1960-1969
      • 1970-1979
      • 1980-1989
      • 1990-1999
      • 2000-2009
      • 2010-2019
      • 2020-2029
    • Science news
    • Scientific Documentation
  • About us...
    • Biography
    • Bibliography
  • The Method
    • Di Bella's Method!
    • 1998 Trial!
  • Media
    • Video Publications
    • News-PapersNews-Papers
      • Press
    • TestimonialTestimonial
      • Testimonies
    • Video GalleryVideo Gallery
      • Congresses
      • Video Testimonies
      • TV & C.
  • Case History
    • Medical reports
      • Lung
      • Lymphomas
        • Non-Hodgkin Lymphomas
        • Hodgkin Lymphomas
      • Mediastinum
      • Mesothelioma
      • Myeloma
      • Pancreas
      • Scientific Publications
  • F.A.Q.
  • Useful Links
    • User Side
      • Vademecum
    • CouponChief - Resources for Cancer Patients
  • Contact Us
Home page   News  
Title Created Date
Cancer research: Are the drugs we count on based on bad science? 27 October 2013
How effective is chemo therapy? 07 October 2013
Long-term side-effects. Molecularly targeted therapies hold promise for many pediatric cancers, but at what cost? 19 July 2013
Are we treating cancer, but killing the patient? 06 April 2013
Radiation generates cancer stem cells from less aggressive breast cancer cells! 22 February 2013
Melatonin's role in cancer 17 January 2013
Chemo can backfire, make cancer worse! 12 December 2012
Display # 

Search

Follow us...

Latest

  • Therapeutic Potential of Melatonin Counteracting Chemotherapy-Induced Toxicity in Breast Cancer Patients: A Systematic Review
  • Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy
  • Melatonin: A Potential Regulator of DNA Methylation
  • Somatostatin, its receptors and analogs, in lung cancer
  • Melatonin in Combination with Albendazole or Albendazole Sulfoxide Produces a Synergistic Cytotoxicity against Malignant Glioma Cells through Autophagy and Apoptosis
  • Somatostatin receptor-targeted anti-cancer therapy
  • Somatostatin and analogues in the treatment of cancer. A review
  • Potential of Melatonin as Adjuvant Therapy of Oral Cancer in the Era of Epigenomics
  • Biology of somatostatin in breast cancer
  • Melatonin inhibited the progression of gastric cancer induced by Bisphenol S via regulating the estrogen receptor 1
  • 1,25-Dihydroxyvitamin D3 induces programmed cell death in a rat glioma cell line
  • Prolactin and its receptor as therapeutic targets in glioblastoma multiforme
  • Stimulation of prolactin receptor induces STAT-5 phosphorylation and cellular invasion in glioblastoma multiforme
  • Vitamin D inhibits osteosarcoma by reprogramming nonsense-mediated RNA decay and SNAI2-mediated epithelial-to-mesenchymal transition
  • Melatonin inhibits 17β-estradiol-induced migration, invasion and epithelial-mesenchymal transition in normal and endometriotic endometrial epithelial cells
  • Peptide Radioligands in Cancer Theranostics: Agonists and Antagonists
  • Osteogenesis from Dental Pulp Derived Stem Cells: A Novel Conditioned Medium Including Melatonin within a Mixture of Hyaluronic, Butyric, and Retinoic Acids
  • About melatonin - 1996

Most Read

  • The Di Bella Method (DBM)
  • All-trans-retinoic acid and cancer
  • About melatonin - 1996
  • Biography
  • The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
  • Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
  • Bibliography
  • Somatostatin in oncology, the overlooked evidences
  • Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
  • Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
  • How effective is chemo therapy?
  • Vademecum
  • Frequently Asked Questions
  • Complete objective response to biological therapy of plurifocal breast carcinoma
  • Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
  • Declaration recommends eliminate the use of Impact factor for research evaluation
  • Malignant pleural mesothelioma, stage T3-T4 - Consideration of a case study
  • Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients